US Broker Ratings

Solventum Corporation (SOLV) Stock Analysis: Unpacking a 4.16% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV) stands as a notable player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $13.66 billion,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 29.97% Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a pioneering force in the biotechnology sector, stands at the forefront of developing groundbreaking treatments for a variety of autoimmune and..

Universal Health Services (UHS) Stock Analysis: Exploring a 47% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands out in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $8.86 billion,..

Takeda Pharmaceutical Company (TAK) Stock Analysis: A 30% Upside Potential Beckons Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK) has long been a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With..

The Cigna Group (CI) Stock Analysis: Exploring a 14.4% Upside Potential in the Healthcare Sector

The Cigna Group (CI), a stalwart in the healthcare sector, presents a compelling investment opportunity with a potential upside of 14.4% according to analyst expectations. This..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Robust Revenue Growth and Strategic Positioning in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out in the healthcare sector as a formidable player in the diagnostics and research industry. With a market capitalization of..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a 34.59% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the medical instruments and supplies sector, offers a compelling investment opportunity with a potential upside of..

Axsome Therapeutics (AXSM) Stock Analysis: 57% Revenue Growth Propels Exciting Prospects

Investors have been closely watching Axsome Therapeutics, Inc. (NASDAQ: AXSM), a burgeoning player in the biotechnology sector, renowned for its innovative treatments for central nervous system..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 30.82% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a notable player in the healthcare sector under the Health Information Services industry, presents a compelling case for investors focusing on growth..

Medtronic plc (MDT) Stock Analysis: Discovering a Potential 22% Upside in the Medical Device Giant

Medtronic plc (MDT), a formidable player in the healthcare sector, specifically within the medical devices industry, is capturing the attention of investors with a noteworthy potential..

Insmed Incorporated (INSM) Stock Analysis: Exploring a Potential 101.96% Upside in the Biotech Arena

Insmed Incorporated (Nasdaq: INSM) has emerged as a noteworthy player in the biotechnology sector, captivating investor attention with an impressive potential upside of 101.96%. As the..

Regencell Bioscience Holdings (RGC): Investor Outlook on the TCM Innovator with a $9.31 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a prominent player in the healthcare sector, commands attention with its focus on Traditional Chinese Medicine (TCM) biosciences. Operating out..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 10% Upside Potential with Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $29.53 billion,..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Biotech Powerhouse with 39.43% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector with its focus on RNA-targeted medicines, offering a robust pipeline and strategic partnerships that position..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Market Position

For investors eyeing opportunities within the healthcare sector, DaVita Inc. (NYSE: DVA) stands out as a prominent player in the medical care facilities industry. With a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 42.79% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a key player in the Healthcare sector, offers a compelling investment opportunity as it navigates the dynamic landscape of the Medical..

Tenet Healthcare Corporation (THC) Stock Analysis: Why a 39% Potential Upside is Captivating Investors

Tenet Healthcare Corporation (NYSE: THC) stands at a pivotal moment in the healthcare sector, presenting a compelling investment opportunity with a substantial potential upside of 39.48%...

Danaher Corporation (DHR) Investor Outlook: Analyzing a Potential 34.56% Upside in the Diagnostics & Research Sector

Danaher Corporation (NYSE: DHR) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Washington, D.C., this $127.47..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Healthcare Innovator’s Performance and Prospects

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its innovative approach to..

Stryker Corporation (SYK): Potential 23.89% Upside Amid Robust Buy Ratings and Strategic Growth

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, has been drawing significant attention from investors, thanks to its promising growth potential and strong..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds